These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 8133271

  • 1. Binding of cholecystokinin-8 (CCK-8) peptide derivatives to CCKA and CCKB receptors.
    Schäfer U, Harhammer R, Boomgaarden M, Sohr R, Ott T, Henklein P, Repke H.
    J Neurochem; 1994 Apr; 62(4):1426-31. PubMed ID: 8133271
    [Abstract] [Full Text] [Related]

  • 2. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve.
    Corp ES, McQuade J, Moran TH, Smith GP.
    Brain Res; 1993 Sep 24; 623(1):161-6. PubMed ID: 8221086
    [Abstract] [Full Text] [Related]

  • 3. A segment of five amino acids in the second extracellular loop of the cholecystokinin-B receptor is essential for selectivity of the peptide agonist gastrin.
    Silvente-Poirot S, Wank SA.
    J Biol Chem; 1996 Jun 21; 271(25):14698-706. PubMed ID: 8663021
    [Abstract] [Full Text] [Related]

  • 4. A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.
    Knapp RJ, Vaughn LK, Fang SN, Bogert CL, Yamamura MS, Hruby VJ, Yamamura HI.
    J Pharmacol Exp Ther; 1990 Dec 21; 255(3):1278-86. PubMed ID: 2262906
    [Abstract] [Full Text] [Related]

  • 5. High affinity binding of cholecystokinin to small cell lung cancer cells.
    Yoder DG, Moody TW.
    Peptides; 1987 Dec 21; 8(1):103-7. PubMed ID: 3033616
    [Abstract] [Full Text] [Related]

  • 6. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179.
    Silvente Poirot S, Hadjiivanova C, Escrieut C, Dufresne M, Martinez J, Vaysse N, Fourmy D.
    Eur J Biochem; 1993 Mar 01; 212(2):529-38. PubMed ID: 8444190
    [Abstract] [Full Text] [Related]

  • 7. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
    Povoski SP, Zhou W, Longnecker DS, Bell RH.
    Oncol Res; 1994 Mar 01; 6(9):411-7. PubMed ID: 7703527
    [Abstract] [Full Text] [Related]

  • 8. [125I]SNF 8702: a selective radioligand for CCKB receptors.
    Slaninova J, Knapp RJ, Weber SJ, Davis TP, Fang SN, Hruby VJ, Yamamura HI.
    Peptides; 1995 Mar 01; 16(2):221-4. PubMed ID: 7784252
    [Abstract] [Full Text] [Related]

  • 9. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
    Durieux C, Ruiz-Gayo M, Corringer PJ, Bergeron F, Ducos B, Roques BP.
    Mol Pharmacol; 1992 Jun 01; 41(6):1089-95. PubMed ID: 1614411
    [Abstract] [Full Text] [Related]

  • 10. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
    Zhou W, Povoski SP, Bell RH.
    J Surg Res; 1995 Mar 01; 58(3):281-9. PubMed ID: 7533864
    [Abstract] [Full Text] [Related]

  • 11. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
    Huang SC, Zhang L, Chiang HC, Wank SA, Maton PN, Gardner JD, Jensen RT.
    Am J Physiol; 1989 Jul 01; 257(1 Pt 1):G169-74. PubMed ID: 2473653
    [Abstract] [Full Text] [Related]

  • 12. A study of the cerebral cortex cholecystokinin receptor using two radiolabelled probes: evidence for a common CCK 8 and CCK 4 cholecystokinin receptor binding site.
    Clark CR, Daum P, Hughes J.
    J Neurochem; 1986 Apr 01; 46(4):1094-101. PubMed ID: 3005503
    [Abstract] [Full Text] [Related]

  • 13. CCK-JMV-180: a peptide that distinguishes high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptors.
    Stark HA, Sharp CM, Sutliff VE, Martinez J, Jensen RT, Gardner JD.
    Biochim Biophys Acta; 1989 Feb 09; 1010(2):145-50. PubMed ID: 2463851
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and biological evaluation of cholecystokinin analogs in which the Asp-Phe-NH2 moiety has been replaced by a 3-amino-7-phenylheptanoic acid or a 3-amino-6-(phenyloxy)hexanoic acid.
    Amblard M, Rodriguez M, Lignon MF, Galas MC, Bernad N, Artis-Noël AM, Hauad L, Laur J, Califano JC, Aumelas A.
    J Med Chem; 1993 Oct 01; 36(20):3021-8. PubMed ID: 7692048
    [Abstract] [Full Text] [Related]

  • 15. Cholecystokinin and gastrin are not equally sensitive to GTP gamma S at CCKB receptors: importance of the sulphated tyrosine.
    Lallement JC, Oiry C, Lima-Leite AC, Lignon MF, Fulcrand P, Galleyrand JC, Martinez J.
    Eur J Pharmacol; 1995 Jul 18; 290(2):61-7. PubMed ID: 8575534
    [Abstract] [Full Text] [Related]

  • 16. Characterization of cholecystokinin receptors on the sphincter of Oddi.
    Cox KL, von Schrenck T, Moran TH, Gardner JD, Jensen RT.
    Am J Physiol; 1990 Nov 18; 259(5 Pt 1):G873-81. PubMed ID: 2240227
    [Abstract] [Full Text] [Related]

  • 17. Type B cholecystokinin receptors on rat glioma C6 cells. Binding studies and measurement of intracellular calcium mobilization.
    Kaufmann R, Lindschau C, Schöneberg T, Haller H, Henklein P, Boomgaarden M, Ott T.
    Brain Res; 1994 Mar 07; 639(1):109-14. PubMed ID: 8180826
    [Abstract] [Full Text] [Related]

  • 18. Reduction of [125I]Bolton Hunter CCK8 and [3H]MK-329 (devazepide) binding to CCK receptors in the substantia nigra/VTA complex and its forebrain projection areas following MPTP-induced hemi-parkinsonism in the monkey.
    Graham WC, Hill DR, Woodruff GN, Sambrook MA, Crossman AR.
    Neurosci Lett; 1991 Sep 30; 131(1):129-34. PubMed ID: 1791971
    [Abstract] [Full Text] [Related]

  • 19. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
    Boteju LW, Nikiforovich GV, Haskell-Luevano C, Fang SN, Zalewska T, Stropova D, Yamamura HI, Hruby VJ.
    J Med Chem; 1996 Sep 27; 39(20):4120-4. PubMed ID: 8831778
    [Abstract] [Full Text] [Related]

  • 20. Characteristics of 125I-Bolton-Hunter labelled cholecystokinin binding in human brain.
    Cross AJ, Slater P, Skan W.
    Neuropeptides; 1988 Sep 27; 11(2):73-6. PubMed ID: 3368039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.